Lilly Exploring Strategic Alternatives for Animal Health Biz Post author:Sam Post published:January 31, 2018 Post category:BioPharma Sluggish growth is the main driver for the decision.. Source: BioSpace You Might Also Like Alimera Sciences To Report Second Quarter 2017 Financial Results On August 2nd, 2017 July 23, 2017 Zymeworks Announces Partial Exercise Of Over-Allotment Option For Its Initial Public Offering May 25, 2017 Boston's Intarcia Pink Slips 60 Employees, Terminates Two Late-Stage Trials February 4, 2018
Zymeworks Announces Partial Exercise Of Over-Allotment Option For Its Initial Public Offering May 25, 2017
